Results 161 to 170 of about 48,959 (314)

Epistemic diversity and the politics of knowledge in plant disease management: Insights from the Xylella fastidiosa epidemic in southern Italy

open access: yesPLANTS, PEOPLE, PLANET, EarlyView.
Xylella fastidiosa is a major plant pathogen affecting crops such as grapes, citrus, almonds, and olives, with potentially severe consequences for agricultural production and rural livelihoods worldwide. This paper examines the conflict around the management of the X. fastidiosa outbreak affecting olive trees in southern Italy.
Fabio Gatti   +2 more
wiley   +1 more source

Exploring Costa Rica's fungal trends: Insights from digitized specimens

open access: yesPLANTS, PEOPLE, PLANET, EarlyView.
Fungi are essential to tropical ecosystems but remain largely absent from conservation agendas. By analyzing over 78,000 fungal records from Costa Rica—a globally recognized biodiversity hotspot—this study reveals key patterns in fungal diversity, distribution, and seasonality.
Melissa Mardones   +2 more
wiley   +1 more source

Pesticide use in integrated pest and pollinator management framework to protect pollinator health

open access: yesPest Management Science, Volume 81, Issue 4, Page 1691-1696, April 2025.
Integrated pest management (IPM) emphasizes non‐chemical methods, with pesticides as a last resort, while integrated pest and pollinator management (IPPM) integrates pollinator health into pest control strategies. Abstract Agricultural pesticides have historically been a critical tool in controlling pests and diseases, preventing widespread suffering ...
Ngoc T Phan   +6 more
wiley   +1 more source

Harnessing Natural Compounds in Psoriasis: Targeting Cellular Pathways for Effective Therapy

open access: yesPhytotherapy Research, EarlyView.
Natural compounds act on key cellular pathways in psoriasis by suppressing keratinocyte hyperproliferation, modulating Th17/IL‐17‐mediated immune responses, and reducing oxidative stress. These multi‐target effects highlight their potential as safer adjunctive therapies alongside conventional treatments.
Hye Jin Lee   +9 more
wiley   +1 more source

Ashwagandha: Is It Safe? Part 2: A Preclinical Evidence Review

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT The preclinical evidence for the safety of ashwagandha (Withania somnifera (L.) Dunal, AS) is reviewed, and its preparations (extracts) and constituents, from the general toxicity in animal models to in vitro and cell culture studies, which may elucidate mechanisms of action and explain clinical case reports.
Elizabeth M. Williamson, Thomas Brendler
wiley   +1 more source

Home - About - Disclaimer - Privacy